Latest Ribbon symbolism Stories
Cancer survivors who had chest radiation are nearly twice as likely to die in the years after having major heart surgery as similar patients who didn't have radiation, according to research in the American Heart Association journal Circulation. Chest radiation to kill or shrink breast cancer, Hodgkin's lymphoma and other cancers increases survivors' risk for major heart disease years — even decades — after radiation therapy. "While radiation treatments done on children and adults in...
Is the era of targeted therapy for breast cancer at hand? It could be, said experts at the Lester and Sue Smith Breast Center at Baylor College of Medicine – at least for a certain population of women. In a report that appears online today in the Journal of Clinical Oncology, the researchers have shown that a subset of breast cancer patients who have tumors overexpressing a protein called the human epidermal growth factor receptor 2 (HER-2 positive) may benefit from a combination of...
Preclinical Results Presented at AACR 2013 Examines ErbB3-Targeted Antibody for the Treatment of ER+ Breast Cancer CAMBRIDGE, Mass., April 8, 2013 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) today announced preclinical study results showing that the novel therapy MM-121 restores tumor sensitivity and delays the onset of resistance to the aromatase inhibitor, letrozole, in an ER+ breast cancer model. The study was presented as part of the American Association for...
New book "The Healing Journey of My Bodacious Ta ta's" explores preventative, holistic options for allowing the body to heal itself Houston, Texas (PRWEB) April 08, 2013 When Venus DeMarco was diagnosed with breast cancer, she sought help from conventional means: doctors and specialists. But after weighing her options, DeMarco realized that she didn’t have to go through surgery, chemotherapy or radiation: the only thing she had to do was change her lifestyle. In her...
AHRA members to play important role in early breast cancer diagnosis through communication and organizational resources. Sudbury, MA (PRWEB) April 05, 2013 AHRA: The Association for Medical Imaging Management Board of Directors has endorsed Are You Dense Advocacy, Inc. and its efforts to standardize the communication of dense breast tissue. This includes support of breast density notification laws and expanded insurance coverage screening legislation. Connecticut was the first state to...
CNC Software Developer BobCAD-CAM Helps Raise Money for Cancer Victim Clearwater, Florida (PRWEB) April 05, 2013 Nothing could ever prepare someone for the words "You have cancer." And nothing could ever prepare someone to receive news that a family member or loved one has been diagnosed with cancer. Not that long ago, the CEO of BobCAD-CAM, Larry Pendleton, received that call. His sister Wendy had been diagnosed with Stage IV breast cancer. Wendy is a wife, mother, daughter,...
Physician-researchers at UT Southwestern Medical Center have identified a vulnerability of certain lung-cancer cells – a specific genetic weakness that can be exploited for new therapies. Although researchers have long known that mutant versions of the KRAS gene drive tumor formation and are key to cell survival in non-small cell lung cancer, the blocking of activated KRAS has proven difficult. For years, investigations have explored stopping lung cancer at this junction, which also...
Gift to The Wistar Institute to Fund Triple Negative Breast Cancer Treatment Research WEST CHESTER, Pa., April 4, 2013 /PRNewswire/ -- QVC and the Fashion Footwear Association of New York (FFANY), building on a 19 year philanthropic relationship supporting breast cancer research, have announced a $140,000 grant to fund research at The Wistar Institute on a specific and deadly form of breast cancer called triple negative. "The mission of the QVC-FFANY relationship is to support the...
Complete Results from Positive Clinical Validation Study to be Presented at 2013 American Urological Association (AUA) Annual Meeting REDWOOD CITY, Calif., April 3, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the clinical trial results validating its biopsy-based Oncotype DX® prostate cancer test will be presented by investigators from the University of California, San Francisco (UCSF) in an oral session at the American Urological Association...
A team of international cancer researchers led by Dr. Mathieu Lupien at the Princess Margaret Cancer Centre, University Health Network, has identified the signalling pathway that is over-activated in estrogen receptor (ER)-positive breast cancer cells that are resistant to hormone therapies such as tamoxifen, aromatase inhibitors or fulvestrant. Resistance to hormone therapy is reported in almost half of ER-positive breast cancer patients and no cure is currently available. The fact that...
